Search by Drug Name or NDC

    NDC 00078-0778-03 NEVANAC 1 mg/mL Details

    NEVANAC 1 mg/mL

    NEVANAC is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is NEPAFENAC.

    Product Information

    NDC 00078-0778
    Product ID 0078-0778_b60c701f-95ea-4053-b93e-90a1b23deb96
    Associated GPIs
    GCN Sequence Number 059670
    GCN Sequence Number Description nepafenac DROPS SUSP 0.1 % OPHTHALMIC
    HIC3 Q6P
    HIC3 Description EYE ANTI-INFLAMMATORY AGENTS
    GCN 25416
    HICL Sequence Number 033195
    HICL Sequence Number Description NEPAFENAC
    Brand/Generic Brand
    Proprietary Name NEVANAC
    Proprietary Name Suffix n/a
    Non-Proprietary Name nepafenac
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION/ DROPS
    Route OPHTHALMIC
    Active Ingredient Strength 1
    Active Ingredient Units mg/mL
    Substance Name NEPAFENAC
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021862
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0778-03 (00078077803)

    NDC Package Code 0078-0778-03
    Billing NDC 00078077803
    Package 3 mL in 1 BOTTLE (0078-0778-03)
    Marketing Start Date 2022-07-05
    NDC Exclude Flag N
    Pricing Information N/A